Literature DB >> 18715802

Regulation of CD8(+) T cell functions by RARgamma.

Claire Gordy1, Ivan Dzhagalov, You-Wen He.   

Abstract

Retinoic acid plays a key role in the development and function of the immune system; however, the contribution of each of the three retinoic acid receptors (RARs) to the T cell immune response is not yet well understood. Of these receptors, both RARalpha and RARgamma are expressed in T lymphocytes. While possible functional redundancy thus complicates understanding of the role of each receptor in T cells, emerging data suggest that RARalpha and RARgamma function differently in thymocyte development and that RARgamma is required for both primary and secondary CD8(+) T cell immune responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715802      PMCID: PMC2615478          DOI: 10.1016/j.smim.2008.07.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  64 in total

1.  Retinoic acid amplifies the host immune response to LPS through increased T lymphocytes number and LPS binding protein expression.

Authors:  Carole Seguin-Devaux; Didier Hanriot; Michèle Dailloux; Véronique Latger-Cannard; Faiez Zannad; Paul-Michel Mertes; Dan Longrois; Yvan Devaux
Journal:  Mol Cell Endocrinol       Date:  2005-11-23       Impact factor: 4.102

2.  Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha.

Authors:  Z Szondy; U Reichert; J M Bernardon; S Michel; R Tóth; E Karászi; L Fésüs
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

3.  Murine isoforms of retinoic acid receptor gamma with specific patterns of expression.

Authors:  P Kastner; A Krust; C Mendelsohn; J M Garnier; A Zelent; P Leroy; A Staub; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Expression and regulation of nuclear retinoic acid receptors in human lymphoid cells.

Authors:  Mark Ballow; Xiaochuan Wang; Shunan Xiang; Cheryl Allen
Journal:  J Clin Immunol       Date:  2003-01       Impact factor: 8.317

5.  9-cis-retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development.

Authors:  Y Yang; M S Vacchio; J D Ashwell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

6.  Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes.

Authors:  M G Mattei; M Rivière; A Krust; S Ingvarsson; B Vennström; M Q Islam; G Levan; P Kautner; A Zelent; P Chambon
Journal:  Genomics       Date:  1991-08       Impact factor: 5.736

7.  Mouse retinoic acid receptor alpha 2 isoform is transcribed from a promoter that contains a retinoic acid response element.

Authors:  P Leroy; H Nakshatri; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

8.  Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes.

Authors:  M Iwata; M Mukai; Y Nakai; R Iseki
Journal:  J Immunol       Date:  1992-11-15       Impact factor: 5.422

9.  Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.

Authors:  M Leid; P Kastner; R Lyons; H Nakshatri; M Saunders; T Zacharewski; J Y Chen; A Staub; J M Garnier; S Mader
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

10.  TISSUE CHANGES FOLLOWING DEPRIVATION OF FAT-SOLUBLE A VITAMIN.

Authors:  S B Wolbach; P R Howe
Journal:  J Exp Med       Date:  1925-11-30       Impact factor: 14.307

View more
  4 in total

1.  Detection of retinoid receptors in non-neoplastic canine lymph nodes and in lymphoma.

Authors:  Carlos H de Mello Souza; Victor E O Valli; Barbara E Kitchell
Journal:  Can Vet J       Date:  2014-01       Impact factor: 1.008

2.  Pilot Study of a Novel Therapeutic Approach for Refractory Advanced Stage Folliculotropic Mycosis Fungoides.

Authors:  Christina A Del Guzzo; Neha N Jariwala; Paul L Haun; Kelly M MacArthur; Christen M Mowad; Elisabeth G Richard; Joseph P Holton; Alain H Rook
Journal:  Acta Derm Venereol       Date:  2020-06-18       Impact factor: 3.875

3.  Alitretinoin in the treatment of cutaneous T-cell lymphoma.

Authors:  Till Kaemmerer; Pia-Charlotte Stadler; Leonie Helene Frommherz; Anne Guertler; Lars Einar French; Markus Reinholz
Journal:  Cancer Med       Date:  2021-08-25       Impact factor: 4.452

4.  Selective Retinoic Acid Receptor γ Antagonist 7C is a Potent Enhancer of BMP-Induced Ectopic Endochondral Bone Formation.

Authors:  Daisuke Tateiwa; Takashi Kaito; Kunihiko Hashimoto; Rintaro Okada; Joe Kodama; Junichi Kushioka; Zeynep Bal; Hiroyuki Tsukazaki; Shinichi Nakagawa; Yuichiro Ukon; Hiromasa Hirai; Hongying Tian; Ivan Alferiev; Michael Chorny; Satoru Otsuru; Seiji Okada; Masahiro Iwamoto
Journal:  Front Cell Dev Biol       Date:  2022-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.